201 related articles for article (PubMed ID: 35643508)
1. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).
Turner HC; Ottesen EA; Bradley MH
Parasit Vectors; 2022 May; 15(1):181. PubMed ID: 35643508
[TBL] [Abstract][Full Text] [Related]
2. The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).
Turner HC; Bettis AA; Chu BK; McFarland DA; Hooper PJ; Ottesen EA; Bradley MH
Infect Dis Poverty; 2016 May; 5(1):54. PubMed ID: 27388873
[TBL] [Abstract][Full Text] [Related]
3. The global programme to eliminate lymphatic filariasis: health impact after 8 years.
Ottesen EA; Hooper PJ; Bradley M; Biswas G
PLoS Negl Trop Dis; 2008 Oct; 2(10):e317. PubMed ID: 18841205
[TBL] [Abstract][Full Text] [Related]
4. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
Chu BK; Hooper PJ; Bradley MH; McFarland DA; Ottesen EA
PLoS Negl Trop Dis; 2010 Jun; 4(6):e708. PubMed ID: 20532228
[TBL] [Abstract][Full Text] [Related]
5. The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs.
Mathew CG; Bettis AA; Chu BK; English M; Ottesen EA; Bradley MH; Turner HC
Clin Infect Dis; 2020 Jun; 70(12):2561-2567. PubMed ID: 31343064
[TBL] [Abstract][Full Text] [Related]
6. Health economic analyses of the Global Programme to Eliminate Lymphatic Filariasis.
Turner HC
Int Health; 2020 Dec; 13(Suppl 1):S71-S74. PubMed ID: 33349885
[TBL] [Abstract][Full Text] [Related]
7. Elimination of lymphatic filariasis as a public health problem in Malawi.
Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
[TBL] [Abstract][Full Text] [Related]
8. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
[TBL] [Abstract][Full Text] [Related]
9. Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis.
Turner HC; Bettis AA; Chu BK; McFarland DA; Hooper PJ; Mante SD; Fitzpatrick C; Bradley MH
Clin Infect Dis; 2017 Mar; 64(6):728-735. PubMed ID: 27956460
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.
Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R
Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883
[TBL] [Abstract][Full Text] [Related]
11. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
Ramaiah KD; Ottesen EA
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3319. PubMed ID: 25412180
[TBL] [Abstract][Full Text] [Related]
12. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
Devi RR; Raju V
J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
[TBL] [Abstract][Full Text] [Related]
13. The role of medicine donations in the global programme for the elimination of lymphatic filariasis.
Williams T; Taylor R; Iwamoto M; Hida T; Gusovsky F
Int Health; 2020 Dec; 13(Suppl 1):S39-S43. PubMed ID: 33349878
[TBL] [Abstract][Full Text] [Related]
14. Global programme to eliminate lymphatic filariasis: progress report, 2016.
Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
[No Abstract] [Full Text] [Related]
15. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
Ottesen EA; Horton J
Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877
[TBL] [Abstract][Full Text] [Related]
16. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Hooper PJ; Bradley MH; Biswas G; Ottesen EA
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
[TBL] [Abstract][Full Text] [Related]
17. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage.
Stone CM; Kastner R; Steinmann P; Chitnis N; Tanner M; Tediosi F
BMJ Glob Health; 2016; 1(1):e000021. PubMed ID: 28588916
[TBL] [Abstract][Full Text] [Related]
18. A game-theoretic model of lymphatic filariasis prevention.
Rychtář J; Taylor D
PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010765. PubMed ID: 36137005
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs.
Gedge LM; Bettis AA; Bradley MH; Hollingsworth TD; Turner HC
Parasit Vectors; 2018 Feb; 11(1):75. PubMed ID: 29391042
[TBL] [Abstract][Full Text] [Related]
20. Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.
Kapa DR; Mohamed AJ
Int Health; 2020 Dec; 13(Suppl 1):S17-S21. PubMed ID: 33349881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
